CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

Oak Street Health, a subsidiary of CVS, is paying $60 million to the federal government to resolve allegations that it ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

The method comprises receiving, by a substance management system, a dosage instruction for administering a substance to an ...

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.